Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	152
Overall Study	STARTED	Vortioxetine 5 mg	144
Overall Study	STARTED	Vortioxetine 10 mg	150
Overall Study	STARTED	Vortioxetine 20 mg	154
Overall Study	Treated	Placebo	152
Overall Study	Treated	Vortioxetine 5 mg	144
Overall Study	Treated	Vortioxetine 10 mg	148
Overall Study	Treated	Vortioxetine 20 mg	150
Overall Study	COMPLETED	Placebo	136
Overall Study	COMPLETED	Vortioxetine 5 mg	127
Overall Study	COMPLETED	Vortioxetine 10 mg	132
Overall Study	COMPLETED	Vortioxetine 20 mg	132
Overall Study	NOT COMPLETED	Placebo	16
Overall Study	NOT COMPLETED	Vortioxetine 5 mg	17
Overall Study	NOT COMPLETED	Vortioxetine 10 mg	18
Overall Study	NOT COMPLETED	Vortioxetine 20 mg	22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01255787/flow